Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a great idea!
"Frenchbroad's statement was factually accurate." So what? I never suggested otherwise.
Your input is every bit as invaluable as the lack of substantive information about the brilacidin presentation provided by Dr. Gow.
I believe I made a few points. You either missed them or dismissed them but I believed them to be valid points.
The sequence of events:
In JULY a link was posted to an October 23 meeting on this board. There was nothing in that post other than that link.
Between the time of that post and the meeting itself there were a dozen posts promoting it.
I believe that the Company itself never mentioned it during that time. (Feel free to check me on that.)
In spite of the anticipation of of the meeting 10/23 came and went without a mention of it here and on 11/2 I posted this:
"I'm not convinced that a presentation even occurred. No one has stepped up to confirm it in spite of all the hype beforehand.
Frenchbroad...can you confirm it? Can anyone confirm it?"
No definitive response was provided by ANYONE until on 11/5 olden_grumpini opined "I think the Dr. Goldman presentation at TIMM went as planned" and referred to a photo of the TIMM X feed that purported to show it.
I signed up for X and posted the photo itself yesterday, establishing hard evidence that the presentation was made for the first time on this board (something promoters of the meeting had obviously failed to do).
Then yesterday, after failing to provide any response to my query about whether the presentation occurred (aka "no information"), Frenchbroad posted this: "Dr. Gow posted information about the Brilacidin presentation and a photograph of Dr. Goldman in his Twitter account."
Dr. Gow had actually posted that "information" to his X account on the day of the presentation!!! If only we had known.
My issue was with what was being described as "information about the Brilacidin presentation" when in fact the only information provided was that there was one.
As of this moment there have been zero details provided about the presentation by CEO Leo Ehrlich or anyone else. If you can offer a suggestion as to why that might be the case I'd love to hear it. Perhaps he felt it didn't include anything newsworthy.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0069
-0.0015 (-17.86%)
Volume: 704,118
Total Trades: 45
Dollar Volume: $ 5,520
"Now you assert that Dr. Gow posted information about the Brilacidin presentation but fail to provide that information...."
And here's why. This is all he said:
Neil Gow
@neil_gow
Oct 23
Gustavo Goldman describes how the host defence peptide brilacidin strongly synergies with caspofungin in inhibiting Aspergillus and a range of other fungal pathogens.
That's some serious information.
Earthshaking revelations all around.
"The suggestion maybe Dr. Goldman never presented Brilacidin in the Athens conference is an other silly try to hope Ipix investors will chase their tail and worry."
It was an open question to you and others, only posed because the Company never confirmed that the presentation had occurred. It was never answered definitively until I did so myself today.
Now you assert that Dr. Gow posted information about the Brilacidin presentation but fail to provide that information....
I put your post through Google Translate and it came back "Language Not Recognized".
"It's amazing you would question someone who's posts have been mostly leaning to negative."
Who's that?
"Did Absentee Ehrlich even mention the presentation or was it Frenchbroad? Can't recall."
Neither. First mention was at https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172415276 . Your guess is as good as mine as to how that happened.
I don't think Ehrlich has mentioned it YET.
Thanks for piping up o_g. I was almost tempted to go to X to confirm but I have privacy concerns. Your qualifier ("I think....") still has me a little bit concerned. Please let me know if you would be comfortable enough to take it to "I'm quite sure" (which would be good enough for my purposes) or if you run into any other evidence. I'm still thinking that the Company or something Googlable should be telling us more about the presentation itself or at least confirming its occurrence.
ps. Cummins made an interesting information filing on 9/26. I'm sure you'll be able to find it if this link doesn't work (I have the feeling that it won't):
https://www.masscourts.org/eservices/searchresults.page?x=UgjsoEaRLtIunC2DigxCihQKZwnw4WXt8Fw7BX3CiDF1wSv7P9IzVQAFHerBl5S4TYqCLyJfVEj-rn3mRnhMrKOHlEQv4AQaJCwsLZoIon2YJAE8XaUW-P0f-SCOB0dZJo7zYdgEoAOYCwPOfv3fWeicsmqD0IsWOsyWfSwc3ea6wkG36Mv4F5omIEqGPy3F8*D6HMtwAgi6DB7*dFOWQg&antiCache=1699202039277
There seemed to be a whole lot more to like about this Company on Monday, November 18, 2013 at 4:15:49 PM.
Here are the IPIX press release headlines from that year that remain on ipharminc.com after the CEO stripped the website of the releases that he preferred that the public did not read...a shady move if I ever saw one:
December 20, 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
November 04, 2013
Cellceutix to Pursue Significant Conjunctivitis and Keratitis Ocular Markets with Novel Antibiotic Brilacidin
October 28, 2013
Cellceutix Enters into New $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
October 21, 2013
Cellceutix Structures for Significant Growth in Upcoming Year
October 14, 2013
Cellceutix Drug Brilacidin May be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
October 10, 2013
Cellceutix Antibiotic Brilacidin Chosen by Elsevier as “Top Project to Watch” in Infectious Disease
September 24, 2013
Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
September 16, 2013
Cellceutix Completes Acquistion of Polymedix Assets
September 09, 2013
Cellceutix Acquires PolyMedix Assets from Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
As of this moment the next listed press release is from February 14, 2011. Two and a half years of history gone without a trace.
As you can see there were plenty of stories told prior to November 18, 2013....even without including the erased Kevetrin and Prurisol PR ticklers and pump job interviews (e.g. https://seekingalpha.com/article/1273221-an-interview-with-leo-ehrlich-cellceutix-ceo)....that could have led a person to say "It's a great time to be a shareholder!".
Things are a bit different today, aren't they? The share price sure is:
Monday, November 18, 2013 at 4:15:49 PM......$1.67
Friday, November 3, 2023 at the close......$0.0084
Can you say that "It's a great time to be a shareholder!" today?
Shouldn't a person who has watched or invested in the Company during that period be thinking twice about that? I haven't heard anybody say it lately.
"Now you want some to believe maybe Dr. Goldman never made a Brilacidin presentation in TIMM conference."
I'm not interested in convincing anyone of anything. It's telling that you would accuse me of that rather than assure me that it happened (which is all that I've been asking).
You STILL haven't answered the question:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173146748
...and btw if your answer is "yes" you can expect to be asked how you know.
"But you can take the effort to count the number and USD value of all Ipix trades for that day?? "
It's funny that you think that I would go to the trouble to do that. In fact, both statistics are provided by Ihub and just a single click away from the page that you're looking at.. I'm surprised that you didn't know that.
"The reasons for your huge obsession to Ipix affairs has interest for me only because you want my large Ipix investment to fail."
That's just not true. I understand your anguish but it's self-inflicted and I do not revel in it.
"The all-time nitpicker forgot the plus sign." Look to the right. My source didn't use one.
0.0084
I agree, but my posts reflect a direct and unedited copy and paste of the data in the Ihub box. On the days such as Thursday Ihub uses minus signs to indicate the downward price movement. On Friday they expect the reader to understand that the absence of a minus sign indicates that the data is positive. (The parens can add confusion to some....talk to Ihub)
"In your Thursday Ipix summary you report:
Innovation Pharmaceuticals Inc (PK)
0.0062
-0.00135 (-17.88%)
In your Friday Ipix summary you report:
Innovation Pharmaceuticals Inc (PK)
0.0084
0.0022 (35.48%)
Here is the correct Friday Ipix summary:
Innovation Pharmaceuticals Inc (PK)
0.0084
+0.0022 (+35.48%)"
The problem lies in the failure of the copy and paste function to pick up the upwards pointing arrow on those days on which the share price increases. As you can see there are no plus signs in the Ihub original...you had to edit them in.
I won't be editing the copy and paste job when I post the stats in the future. Obviously you can provide your own edited set if you like....I wouldn't complain if you did. Meanwhile on the same page that my post appears there's a chart immediately to the right of it that makes the direction of the daily price movement quite clear, so anyone who finds my stat presentation false or misleading has ready access to a clarification.
I have been taking the liberty of adding the Dollar Volume of the days trading. I think it shows that the price movements lately, regardless of direction, have been accompanied by pretty dinky little dollar investments and it is that situation that must change before ANY price movement is considered meaningful....that's why I added it.
If you don't want to post your own set of daily statistics but would like me to add a statistic to mine just let me know what it is and I'll consider it.
ps. In case you missed it I'm still curious to know whether you can add anything to resolve this mystery:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173146748
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0084
0.0022 (35.48%)
Volume: 424,304
Total Trades: 21
Dollar Volume: $3,107
"In the "old days," Hypemaster Ehrlich would have been all over this presentation."
I'm not convinced that a presentation even occurred. No one has stepped up to confirm it in spite of all the hype beforehand.
Frenchbroad...can you confirm it? Can anyone confirm it?
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0062
-0.00135 (-17.88%)
Volume: 1,236,272
Total Trades: 39
Dollar Volume: $8,057
Gustavo? Gustavo? Gustavo?
Sure hope he didn't have a fender bender and get a booboo or get called into a last minute meeting about animal husbandry.
Why hasn't there been a transcript provided of his presentation? It sure hasn't had an effect on the share price...at least not a positive one.
Did he show up? Somebody must know. 10 days later and counting.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.00755
-0.00045 (-5.63%)
Volume: 344,492
Total Trades: 31
Dollar Volume: $ 2,633
Thanks for your diligence....without it an awareness of the accounting change may have taken some time to find its way here.
The public companies on which Green Growth performed audits last year bore little resemblance to IPIX:
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
Lowell Farms Inc.
Akanda Corp.
IGEN Networks
Regnum Corp
There is little likelihood that Green Growth will be in any better position to assist in improving this situation than the prior auditor was:
"there were no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K, except that, as initially reported in Part II, Item 9A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023, the Company reported a material weakness in its internal control over financial reporting during such period related to the Company’s accounting procedures relevant to an unconsolidated foreign investment being insufficiently formal."
"The Audit Committee approved the transition"
Of course they did. What else would Barry the eye guy and Zorik the children's ear, nose and throat guy do? Leo knew what he was doing when he signed them up....no fear of any Audit related issues being raised by that Audit Committee.
Green Growth had a grand total of 4 public company audits in their latest annual report.
This isn't a big deal.....a big deal would be dismissing their auditor and NOT replacing them. Given the comments in the last 10-K that may be in the works.
Do you not know the secret location where Form 8-Ks are hidden?
This change wasn't "personal". A number of firms made the same change which seems to stem from the sale of some Pinnacle Accounts to GreenGrowth.
https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/ipix_8k.htm
From GreenGrowth CPAs
"GreenGrowth CPAs is the leading cannabis CPA firm offering tax, audit and accounting services to the cannabis and medical marijuana industries."
IPIX
Innovation Pharmaceuticals Inc (PK)
0.00815
-0.0001 (-1.21%)
Volume: 214,901
Total Trades: 14
Dollar Volume: $ 1,682
Is that another game changing bit of research? What happened to last Monday's presentation by Scientific Advisor Gustavo? I haven't read a thing about it and the only market reaction since then has been a peewee move downward.
Out, out, brief candle!
Life's but a walking shadow, a poor player
That struts and frets his hour upon the stage,
And then is heard no more. It is yet ANOTHER tale
Told by an idiot, full of sound and fury,
Signifying nothing.
Be nice to read a transcript.
"Linking brilacidin is disingenuous."
I agree that it would be. So is suggesting that someone did that if no one did.
So who did that?
IPIX
Innovation Pharmaceuticals Inc (PK)
0.00825
-0.001 (-10.81%)
Volume: 358,822
Total Trades: 16
Dollar Volume: $ 3,084
Is that a smear too? Or just a sad truth.
My purpose in responding to your post was simply to ask a question: "Are you saying that you are certain that the lead compound in question WASN'T an IPIX compound?"
You chose not to respond to it.
"Other than smearing Ipix by linking it to a failed compound, what was your intention posting your response then? "
IF the failed compound was an IPIX compound (I KNOW IT WASN'T BRILACIDIN) it seemed to me to be reasonable to wonder if Basilea might be pre-disposed to avoid this based on the old "once bitten, twice shy":
"Come on, make the deal Leo!"
Was this not a reasonable question?
"Are you saying that you are certain that the lead compound in question WASN'T an IPIX compound?"
Please answer. And if you have a basis for your answer please provide it.
Obviously if it wasn't an IPIX compound and you know that (versus just hoping it) you would be justified in calling my question a smear. I only intended it to be a good, relevant question and I'm looking forward to your real response.
Pick one:
_ Yes
_ No
I neither said nor suggested that Brilacidin was the lead compound that Basilea sent back...I know that it wasn't.
Are you saying that you are certain that the lead compound in question WASN'T an IPIX compound?
From the same article:
"Basilea’s pivot away from oncology to focus solely on anti-infectives got off to a bumpy start at the beginning of the year, after the biotech’s preclinical profiling of an antifungal program it bought from Fox Chase Chemical Diversity Center for an undisclosed fee led the company to hand the asset back."
The link goes back to https://www.fiercebiotech.com/biotech/first-hiccup-basileas-anti-infective-strategy-biotech-hands-back-antifungal-9-months-after .
Hey Maxamdud and runninggirl(2016)! Sure do miss you guys.
Right back at ya.......🖕
BTW, IPIX board post #400,000! A rare accomplishment.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.00925
0.0004 (4.52%)
Volume: 286,000
Total Trades: 21
Dollar Volume: $ 2,569
"A salon focused on endless debate of the trivial does not appeal to me."
This is how my post ended:
"Are there any trials worth running?
If so, how will they be funded?
There are less than $1M worth of shares available to sell (100M @ $.01).
Are there any assets of value to sell and who would buy them?"
Do you really find those issues trivial?
I'll grant you that they may be moot at this point, but not trivial.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.00885
-0.00015 (-1.67%)
Volume: 41,000
Total Trades: 5
Dollar Volume: $ 361
My problem wasn't with the juvenile images but rather with the lack of an on topic response to the specifics of my post. You just did it again.
"It's funny how people (4 of them so far this time) can find the time to express their feelings about my posts with juvenile cartoon images but can't muster a decent argument to address how they expect the Company to improve on the data they reflect (one of them CAN'T, of course)."
ps. This is 100% true from the perspective of this moderator:
"I'm sure iHub's new TOS has dealt a serious blow to the effort of controlling the narrative about IPIX."
"Had not safety been established earlier? This doesn't seem to pass the smell test. "
What smells is your understanding of the basic requirements for approval.
Substantial evidence of BOTH effectiveness and safety must be shown. If EITHER effectiveness OR safety data weren't established in the study then this statement was correct:
"the supporting data from the GT-201 trial are not sufficiently persuasive to establish substantial evidence of avasopasem’s effectiveness and safety for reducing severe oral mucositis in patients with head and neck cancer."
I think you'll find that the shortfall was in the area of effectiveness. Nothing fishy about it.
https://clinicaltrials.gov/study/NCT03689712?term=galera%20therapeutics&aggFilters=phase:3&cond=mucositis&rank=1&tab=results
IPIX
Innovation Pharmaceuticals Inc (PK)
0.009
0.0001 (1.12%)
Volume: 849,449
Total Trades: 33
Dollar Volume: $ 7,745
"Lot of volume today for this name." The last 3 words being the most important.
"Maybe insiders were front running the big news."
If so, they're some broke-assed insiders.
I can't believe that ANYBODY does. Leo doesn't.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0089
-0.0002 (-2.20%)
Volume: 69,098
Total Trades: 14
Dollar Volume: $618 (couch cushion money)
You can't possibly disagree with this....
"A cautious IPIX investor might wonder why their CPA CEO would invest half of their cash in a business that wasn't adequately transparent in its financial records to assure that the book value and operational effectiveness of BeaMed could be determined with a reasonable degree of confidence."
....unless you don't understand it.
"Is this Ehrlich agreeing with Ehrlich and pointing the finger at Ehrlich?"
Sounds that way, doesn't it? Typically those are 2 different people: "the principal executive officer and principal financial officer of the Company have concluded"
The Exchange Act requires the Company to determine the adequacy of the financial controls that are in place that assure the accuracy of the financials...https://www.sec.gov/spotlight/fcpa/fcpa-recordkeeping.pdf
Without that requirement it's extremely unlikely that the CEO would have revealed his conclusion that "the Company’s disclosure controls and procedures were not effective due to the material weakness in the Company’s internal control over financial reporting as of June 30, 2023".
The specific ineffectiveness is described by the Company:
Material Weakness and Remediation Plan
"As a result of the assessment described above, management concluded that the Company’s accounting procedures relevant to an unconsolidated foreign investment are not sufficiently formal that management can determine whether the applicable control objectives are met and adequate documentation supporting the procedures is in place. Specifically, the Company does not have sufficient controls to conclude that data from the unconsolidated foreign investee underlying the Company’s financial statements is captured completely, accurately and timely, in accordance with the Company’s policies and procedures. This material weakness could result in a misstatement of the recorded equity investment as well as the equity in loss from equity investment that would not be prevented or detected on a timely basis."
The meaning of that is plain enough. IPIX and BeaMed don't have systems in place to assure that BeaMed's reporting is accurate. The CPA CEO is acknowledging that fact and the resulting possibility that the IPIX financials could be inaccurate as a result. Not that they ARE inaccurate, but that they COULD BE.
A cautious IPIX investor might wonder why their CPA CEO would invest half of their cash in a business that wasn't adequately transparent in its financial records to assure that the book value and operational effectiveness of BeaMed could be determined with a reasonable degree of confidence.